NEW YORK (GenomeWeb News) – As part of an expanded agreement between the firms, drug maker Novartis has agreed to help fund development of Gen-Probe's new automated molecular testing platform, Panther, for the blood screening market.

The partners have collaborated since 1998 on nucleic acid tests and instruments for the blood screening market. Under the expanded pact announced today, the firms intend to continue collaborating until the year 2025, and they expect to collaborate on the development of pharmacogenomic tests.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

CNBC reports that Amazon invested in the startup Grail as it sees an opportunity for its cloud computing company in genomics.

Researchers are working on re-making the yeast genome from scratch, according to the Associated Press.

Lawrence Krauss writes at Slate that science is needed for good public policy and should not be ignored.

In Cell this week: functional profiling of Plasmodium genome, a self-inactivating rabies virus, and more.